Transfer factor--current status and future prospects
- PMID: 8993750
- DOI: 10.1007/BF02628649
Transfer factor--current status and future prospects
Abstract
We have detected new clues to the composition and function of "Transfer Factor" using the direct Leucocyte Migration Inhibition (LMI) test as an in vitro assay of Dialysates of Leucocyte Extracts (DLE). This approach has revealed two opposing antigen-specific activities to be present in the same > 3500 < 12,000 DA dialysis fraction - one activity is possessed of Inducer/Helper function (Inducer Factor). The opposing activity is possessed of Suppressor function (Suppressor Factor). When non-immune leucocyte populations are cultured with Inducer Factor they acquire the capacity to respond to specific antigen and inhibition of migration occurs. This conversion to reactivity is antigen-specific and dose-dependent. When immune leucocyte populations are cultured with Suppressor Factor their response to specific antigen is blocked and Inhibition of Migration is prevented.
Similar articles
-
Antigen-specific activity of murine leukocyte dialysates containing transfer factor on human leukocytes in the leukocyte migration inhibition (LMI) assay.J Immunol. 1981 Jan;126(1):80-2. J Immunol. 1981. PMID: 6161170
-
Effects of dialyzable leukocyte extracts with transfer factor activity on leukocyte migration in vitro. 1. Antigen-dependent inhibition and antigen-independent inhibition and enhancement of migration.J Lab Clin Med. 1979 May;93(5):800-18. J Lab Clin Med. 1979. PMID: 429876
-
A new basis for the immunoregulatory activities of transfer factor--an arcane dialect in the language of cells.Cell Immunol. 1983 Nov;82(1):102-16. doi: 10.1016/0008-8749(83)90145-4. Cell Immunol. 1983. PMID: 6227395 Review. No abstract available.
-
In vitro effect of transfer factor on active rosettes and leucocyte migration of patients with cancer.Clin Exp Immunol. 1977 Mar;27(3):416-20. Clin Exp Immunol. 1977. PMID: 324669 Free PMC article.
-
Antigen-specific T-helper and -suppressor factors in the control of the immune response.Immunol Suppl. 1988;1:53-6. Immunol Suppl. 1988. PMID: 2454890 Review.
Cited by
-
Induction and treatment of anergy in murine leprosy.Int J Exp Pathol. 2015 Feb;96(1):31-41. doi: 10.1111/iep.12108. Epub 2014 Dec 21. Int J Exp Pathol. 2015. PMID: 25529580 Free PMC article.
-
Antiviral mode of action of bovine dialyzable leukocyte extract against human immunodeficiency virus type 1 infection.BMC Res Notes. 2011 Nov 1;4:474. doi: 10.1186/1756-0500-4-474. BMC Res Notes. 2011. PMID: 22044844 Free PMC article.
-
Clinical and immunological assessment in breast cancer patients receiving anticancer therapy and bovine dialyzable leukocyte extract as an adjuvant.Exp Ther Med. 2010 May;1(3):425-431. doi: 10.3892/etm_00000066. Epub 2010 May 1. Exp Ther Med. 2010. PMID: 22993557 Free PMC article.
-
Preparation and properties of the specific anti-influenza virus transfer factor.Head Face Med. 2010 Sep 13;6:22. doi: 10.1186/1746-160X-6-22. Head Face Med. 2010. PMID: 20836866 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources